Monthly Archives: December 2017

Roundtable: The Right of Publicity in New York, St. John’s University

An Academic Discussion of Policy Choices in Designing a Publicity/Privacy Rights Regime: Rothman, Buccafusco, & Tushnet The roundtable is on the proposed changes to NY’s ROP, which are very extensive. [I didn’t take notes early on, sorry, but Prof. Rothman … Continue reading

Posted in Uncategorized | Tagged , , | Leave a comment

Court says shoo to Scat’s infringement claim against Dodge

Scat Enterprises, Inc. v. FCA US LLC, 2017 WL 5896182, No. CV 14-7995 (C.D. Cal. Jun. 8, 2017) Scat, a maker of aftermarket car parts, sued over FCA’s use of “Scat Pack” in connection with its Dodge Challenger and Dodge … Continue reading

Posted in Uncategorized | Tagged , , | Leave a comment

Everything’s legal in Jersey: NJ SCt makes class certification harder in price disclosure case

Dugan v. TGI Fridays, Inc., 171 A.3d 620 (N.J. 2017) Plaintiffs alleged that the defendants failed to fairly disclose prices charged to customers for alcoholic and non-alcoholic beverages. The New Jersey Supreme Court held that one set of plaintiffs failed … Continue reading

Posted in Uncategorized | Tagged , , , | Leave a comment

Tick tick boom: Lyme-blocking claim avoids preliminary injunction

Merial, Inc. v. Zoetis, Inc., 2017 WL 4466471, No. 1:17-CV-1624 (N.D. Ga. Jun. 6, 2017) Thorough discussions of the effect of disclaimers on literal falsity/misleadingness are rare, so this one is useful. Merial makes NexGard, flea-and-tick removal treatments; the latter … Continue reading

Posted in Uncategorized | Tagged , | Leave a comment

showing falsity of a noncomparative “tests prove” claim

Strategic Partners Inc. v. Vestagen Protective Techs., Inc., 2017 WL 5897711, No. 16-CV-05900 (C.D. Cal. Jul. 31, 2017) Vestagen sells specialty textiles for healthcare applications, while SPI sells medical apparel; their medical garments with antimicrobial fabrics compete.  Vestagen alleged the … Continue reading

Posted in Uncategorized | Tagged | Leave a comment